Search for: "State v. Bristol-Myers Squibb Co." Results 161 - 180 of 189
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2017, 7:19 am by Kate Howard
Issue: Whether the filing of a putative class action serves, under American Pipe & Construction Co. v. [read post]
21 Jun 2012, 7:40 am by Bexis
Bristol-Myers Squibb Co., 2009 WL 5216982, at *5-6 (D.N.J. [read post]
25 Apr 2015, 11:03 am by Schachtman
Third, the Manual authors state that the doubling argument assumes the “[n]onacceleration of disease. [read post]
16 Jan 2025, 8:45 pm by Josh Blackman
ANZ Securities, Inc. - Opposing counsel was Paul Clement. 4/25/2017 - Bristol-Myers Squibb Co. v. [read post]
27 Feb 2009, 7:00 am
: Kelly and another v GE Healthcare Ltd (IP finance) (Mis)appropriation of Wii and PlayStation brands to name medical disorders (IPKat) Is regulation of trade mark attorneys necessary? [read post]
12 Jan 2017, 7:01 am by John Elwood
United States, 16-309). [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
16 Feb 2010, 4:31 am by Broc Romanek
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]
9 Nov 2015, 7:39 am
BackgroundOno owns a patent relating to immunotherapy -- specifically the use of anti-PD-1 antibodies for treating cancer (and Bristol-Myers Squibb is the exclusive licensee). [read post]
16 Dec 2010, 1:54 pm by Bexis
, 2010 WL 4870149, at *7 (quoting State Farm Florida Insurance Co. v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
2 Jan 2014, 8:08 am by Schachtman
  Bristol Myers Squibb and other companies were inundated by silicone breast implant cases, and plaintiffs had managed to snucker a few juries into returning large verdicts against the defendants. [read post]